Over the past two decades, human embryonic stem cells (hESCs) have gained attention due
to their pluripotent and proliferative ability which enables production of almost all cell types …

The greatest therapeutic promise of human embryonic stem cells (hESC) is to generate
specialized cells to replace damaged tissue in patients suffering from various degenerative …

Human pluripotent stem cell (hPSC)-derived neurons provide exciting opportunities for in
vitro modeling of neurological diseases and for advancing drug development and …

The choice of an optimal strategy of stem cell culture is at the moment an impossible task,
and the elaboration of a culture medium adapted to the production of embryonic and adult …

Human embryonic stem cell (hESC) lines, after directed differentiation, hold the greatest
potential for cell transplantation treatment in many severe diseases. Good manufacturing …

The edict for producing clinically compliant human embryonic stem cells (hESCs)
necessitates adherence to global ethical standards for egg procurement and embryo …

Human embryonic stem cells (hESC) have emerged as attractive candidates for cell-based
therapies that are capable of restoring lost cell and tissue function. These unique cells are …

Background The growth of stem cells in in vitro conditions requires optimal balance between
signals mediating cell survival, proliferation, and self-renewal. For clinical application of …

Clinically compliant human embryonic stem cells (hESCs) should be developed in
adherence to ethical standards, without risk of contamination by adventitious agents. Here …

The generation of induced pluripotent stem cells (iPSCs) from somatic cells has enabled the
possibility of providing unprecedented access to patient‐specific iPSC cells for drug …